Analysts' Opinions Are Mixed on These Healthcare Stocks: CSL (OtherCMXHF) and Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharma Analyst Ratings
TD Cowen Reaffirms Their Buy Rating on Arrowhead Pharmaceuticals (ARWR)
Buy Rating Affirmed for Arrowhead Pharmaceuticals on Promising Asthma Drug Prospects and Market Expansion Potential
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Veeva Systems (VEEV) and Arrowhead Pharmaceuticals (ARWR)
Buy Rating Affirmed for Arrowhead Pharmaceuticals Amid Promising Plozasiran Developments
Arrowhead Pharma Analyst Ratings
Arrowhead Pharma Analyst Ratings
Arrowhead Pharma Analyst Ratings
Arrowhead Pharma Analyst Ratings
Arrowhead Pharma Analyst Ratings
Arrowhead Pharma Analyst Ratings
Arrowhead Pharmaceuticals (ARWR) Gets a Buy From RBC Capital
Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Arrowhead Pharmaceuticals (ARWR) and NovoCure (NVCR)
Hold Rating on Arrowhead Pharmaceuticals' ARO-RAGE Pending Key Clinical Data
Arrowhead Pharmaceuticals: Strong Buy Rating on Expanding Pipeline and Strategic Clinical Advancements
Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Biohaven Ltd. (BHVN) and Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharma Analyst Ratings
Arrowhead Pharma Analyst Ratings
RBC Capital Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR)